AGIOS PHARMACEUTICALS, INC. (CIK: 0001439222) EDGAR, Information, Filings... CompaniesBIO.Com

AGIOS PHARMACEUTICALS, INC.

Mailing address
88 SIDNEY STREET, CAMBRIDGE, Delaware, 02139
Phone
617-649-8600
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

AGIOS PHARMACEUTICALS, INC. (CIK: 0001439222) is an American company incorporated in the state of Massachusetts. Head office is located at 88 SIDNEY STREET, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. AGIOS PHARMACEUTICALS, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

AGIOS PHARMACEUTICALS INC from 2008-01-Jul to 2019-16-Jul

Owner	Filings	Transaction Date	Type of Owner
CAPELLO JEFFREY D	0001224108	Jun-13-2023	director
Owen Catherine E.	0001816838	Jun-13-2023	director
Milanova Tsveta	0001957180	Jan-03-2023	officer: Chief Commercial Officer
Jones Cecilia	0001840056	Sep-26-2022	officer: Chief Financial Officer
Smith Cynthia	0001609480	Aug-11-2022	director
Ballal Rahul D.	0001805097	Aug-11-2022	director
Goff Brian	0001546216	Aug-08-2022	director, officer: Chief Executive Officer
Burns James William	0001900772	Jan-01-2022	officer: Chief Legal Officer
Poddar Richa	0001897274	Dec-06-2021	officer: Chief Commercial Officer
Gheuens Sarah	0001881190	Sep-01-2021	officer: Chief Medical Officer
Washburn Theodore James Jr.	0001874199	Aug-01-2021	officer: Principal Accounting Officer
Miles Darrin	0001840076	Jan-16-2021	officer: Chief Commercial Officer
Car Bruce	0001798876	Jan-06-2020	officer: Chief Scientific Officer
Biller Jonathan	0001744749	Dec-03-2019	officer: Chief Legal Officer
CELGENE CORP /DE/	0000816284	Nov-12-2019	10 percent owner
Celgene European Investment Co LLC	0001577650	Nov-12-2019	10 percent owner
Celgene Alpine Investment Co., LLC	0001581774	Nov-12-2019	10 percent owner
Celgene Switzerland LLC	0001661486	Nov-12-2019	10 percent owner
FOUSE JACQUALYN A	0001405288	Dec-03-2017	director
Scadden David	0001707715	May-27-2017	director
CLARK IAN T	0001336504	Dec-30-2016	director
Alenson Carman	0001688865	Nov-07-2016	officer: Principal Accounting Officer
Hirsch Andrew	0001586707	Sep-19-2016	officer: Chief Financial Officer
Hoerter Steven L.	0001533451	Feb-16-2016	officer: Chief Commercial Officer
Ho Maykin	0001646395	Jun-23-2015	director
Foster-Cheek Kaye I	0001312622	Dec-09-2014	director
THIRD ROCK VENTURES LP	0001408591	Jun-24-2014	10 percent owner
TRV GP, LLC	0001578973	Jun-24-2014	10 percent owner
Third Rock Ventures GP, L.P.	0001578976	Jun-24-2014	10 percent owner
CRANDELL KEITH	0001219039	Jun-23-2014	10 percent owner
NELSEN ROBERT	0001219042	Jun-23-2014	director, 10 percent owner
BYBEE CLINTON	0001219043	Jun-23-2014	10 percent owner
Arch Venture Fund VII LP	0001402439	Jun-23-2014	10 percent owner
ARCH Venture Partners VII, LLC	0001544443	Jun-23-2014	10 percent owner
ARCH Venture Partners VII, L.P.	0001544444	Jun-23-2014	10 percent owner
Bowden Christopher	0001608601	May-31-2014	officer: Chief Medical Officer
STARR KEVIN P	0001192603	May-30-2014	director
Clancy Paul J	0001409601	Sep-24-2013	director
MARAGANORE JOHN	0001180432	Jul-23-2013	director
AFEYAN NOUBAR	0001222012	Jul-23-2013	10 percent owner
KANIA EDWIN M JR	0001255927	Jul-23-2013	10 percent owner
KARSEN PERRY A	0001260573	Jul-23-2013	director
Tessier-Lavigne Marc	0001437435	Jul-23-2013	director
Cole Douglas G.	0001486373	Jul-23-2013	director
Flagship Ventures Fund 2007, L.P.	0001508052	Jul-23-2013	10 percent owner
Flagship Ventures 2007 General Partner LLC	0001508053	Jul-23-2013	10 percent owner
Mak Tak W.	0001542072	Jul-23-2013	10 percent owner
Schenkein David P	0001578200	Jul-23-2013	director, 10 percent owner, officer: Chief Executive Officer
Cantley Lewis Clayton Jr.	0001581950	Jul-23-2013	director, 10 percent owner
Higgons John Duncan	0001581954	Jul-23-2013	10 percent owner, officer: Chief Operating Officer
Biller Scott	0001581956	Jul-23-2013	officer: Chief Scientific Officer
Goddard Glenn	0001581992	Jul-23-2013	officer: Vice President, Finance

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by AGIOS PHARMACEUTICALS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000127 ( Act) Size: 0 KB	Aug-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000125 ( Act) Size: 0 KB	Aug-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000123 ( Act) Size: 0 KB	Aug-12-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001578200-24-000005 (33 Act) Size: 0 KB	Aug-08-2024	001-36014 241188328
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001439222-24-000121 (34 Act) Size: KB	Aug-01-2024	001-36014 241164807
8-K	Document	Current report filing Acc-no: 0001439222-24-000117 (34 Act) Size: KB	Aug-01-2024	001-36014 241164173
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000111 ( Act) Size: 0 KB	Jul-03-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001546216-24-000008 (33 Act) Size: 0 KB	Jul-01-2024	001-36014 241090689
UPLOAD	Document	Acc-no: 0000000000-24-007133 ( Act) Size: KB	Jun-24-2024	001-36014
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000109 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000108 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000107 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000106 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000105 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000104 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000103 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000102 ( Act) Size: 0 KB	Jun-24-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000101 ( Act) Size: 0 KB	Jun-24-2024
8-K	Document	Current report filing Acc-no: 0001193125-24-164555 (34 Act) Size: KB	Jun-20-2024	001-36014 241057361
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001439222-24-000091 ( Act) Size: 0 KB	Jun-17-2024

Recent 20 filings. View all AGIOS PHARMACEUTICALS, INC. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

AGIOS PHARMACEUTICALS, INC. overview
AGIOS PHARMACEUTICALS, INC. job
AGIOS PHARMACEUTICALS, INC. stock
AGIOS PHARMACEUTICALS, INC. ownership
AGIOS PHARMACEUTICALS, INC. CEO
AGIOS PHARMACEUTICALS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.